Top news of the week: 26.12.2022.
In a first, children with rare genetic diseases get mitochondrial transplants from their mothers
Mitochondrial augmentation therapy could provide a way to treat not just rare genetic diseases, but other conditions and injuries arising from mitochondrial damage.
bluebird's SCD Gene Therapy Released from Partial Hold
The FDA lifted its partial clinical hold on bluebird's experimental sickle cell disease gene therapy for patients younger than 18.
The promise of patient-centered biotechnology
Every revolution rises up against an order in need of reform. For the orphan drug revolution, that order was the pharmaceutical industry of the 1970s.
Can COVID-19 Reboot Drug Repurposing?
It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t that be an easy way to speed ...
Climb to Fight Cancer
Take your mountain climbing experience to the next level. Join the CLIMB to Fight Breast Cancer and Climb one of the worlds tallest peaks to support an amazing charity!
Goldman Sachs highlights key healthcare themes for 2023
Goldman Sachs highlights key healthcare themes to follow in 2023 noting that micro factors have become increasingly important despite macro concerns. Read the full story here.
Biotech at Good Entry Point for Investors, Analyst Says Research Report
The company, focused on psychedelic-assisted psychotherapies, is worth more than the CA$10 million the market is valuing it at, noted a Stifel report.
Two Biotech CEOs Charged in Securities Fraud Schemes
A federal grand jury in the District of Maryland returned an indictment that was unsealed today charging two men for their roles in schemes to defraud investors in CytoDyn Inc., a publicly ...